Abstract: A respirable aqueous pharmaceutical composition comprising a neutralizing affinity binder for a virus binding to angiotensin-converting enzyme 2 (ACE2), a buffer, and a solubilizer.

Abstract: In the invention is provided a polypeptide comprising at least 75 amino acids and having an amino acid sequence having at least 90%, such as at least 95%, 96%, 97, 98%, or 99%, such as 100% sequence identity (% SI) with human Angiotensin-converting enzyme 2 (ACE2) (SEQ ID NO 1), for use in the treatment of COVID19, SARS, or MERS, characterized in that the polypeptide is administered pulmonary and/or nasally. Further is provided the polypeptide for use in reducing the number of active virus particles being exhaled by a treated subject infected by SARS-CoV-2, SARS-CoV, or Mers-CoV. Also a dry powder or an aerosol comprising the polypeptide.

Abstract: A pancreatic cancer detection device, including: a solid surface comprising an antibody bound to the solid surface, the solid surface configured to indicate selective binding between the antibody and one or more target protein(s); and wherein the antibody is configured to selectively bind to the target protein(s). In some examples, the target protein(s) include one or more protein(s) selected from the group consisting of Alpha-1 antitrypsin (A1AT), Alpha-1-acid glycoprotein 1 (AGP1), Apolipoprotein A1 (ApoA1), C1-inhibitor, Complement C2, Complement component 3, Carbohydrate antigen 19-9, Calprotectin, caspase-cleaved cytokeratin-18 (CCK18), Ceruloplasmin, cartilage oligomeric matrix protein, gamma-glutamyl transpeptidase, Haptoglobin, Insulin-like growth factor 1, Insulin-Like Growth Factor Binding Protein 3, Properdin, Serum amyloid A, and Tumor necrosis factor alpha (TNF alpha).

Abstract: A method of determining the specific binding of ligand reversibly binding to a binding site in a sample using displacement competitive inhibition. The method comprising incubating the ligand (unlabeled) in the absence of a labeled ligand on a first tissue specimen, incubating the ligand (unlabeled) in the presence of a labeled ligand on a second tissue specimen, the first and the second tissue specimens being adjacent sections of specimen. MALDI imaging mass spectrometry is used to subsequently visualizing bound ligand localization, using in the first and second tissue specimen, respectively.

Abstract: Disclosed is a angiogenesis inhibition determining method using MALDI mass spectrometry, and more particularly, relate to a method for detecting whether small molecules are bound with a target protein and for measuring a binding distribution between the small molecules and the target protein by comparing a result of MALDI mass spectrometry with a result of immunofluorescence of the small molecules, which are used as drugs, for the target protein, and for determining as angiogenesis is inhibited in a portion overlapping with a portion where the drug small molecules are present after the MALDI mass spectrometry in the cell or in the biosample including organelles and a portion where the target protein is present after immunofluorescence, as well as for detecting presence or absence and a distribution state of small molecules used as drugs in a sample by using MALDI mass spectrometry.

Abstract: The invention discloses a method for determining the molar ratio between wild type (WT) BRAF protein and protein variants thereof in a biological sample, comprising the steps of: a) Digesting said sample by using a serine proteinase which specifically cleaves peptide bonds C-terminal to glutamic acid residues or peptide bonds C-terminal to glutamic or aspartic acid residues, to obtain a composition comprising a peptide fragment resulting from digestion of the peptides by the proteinase, wherein the mass of said fragment differs between said wild type (WT) B-raf protein and one said BRAF protein variant. b) Quantitatively assaying the molar amount of the peptide fragment resulting from digestion of wild type (WT) B-raf protein and the molar amount of the peptide fragment resulting from digestion of variants of the wild type (WT) B-raf protein using a mass spectrometry technique.

Abstract: A method of determining the specific binding of ligand reversibly binding to a binding site in a sample using displacement competitive inhibition. The method comprising incubating the ligand (unlabeled) in the absence of a labeled ligand on a first tissue specimen, incubating the ligand (unlabeled) in the presence of a labeled ligand on a second tissue specimen, the first and the second tissue specimens being adjacent sections of specimen. MALDI imaging mass spectrometry is used to subsequently visualizing bound ligand localization, using in the first and second tissue specimen, respectively.

Abstract: Disclosed is a angiogenesis inhibition determining method using MALDI mass spectrometry, and more particularly, relate to a method for detecting whether small molecules are bound with a target protein and for measuring a binding distribution between the small molecules and the target protein by comparing a result of MALDI mass spectrometry with a result of immunofluorescence of the small molecules, which are used as drugs, for the target protein, and for determining as angiogenesis is inhibited in a portion overlapping with a portion where the drug small molecules are present after the MALDI mass spectrometry in the cell or in the biosample including organelles and a portion where the target protein is present after immunofluorescence, as well as for detecting presence or absence and a distribution state of small molecules used as drugs in a sample by using MALDI mass spectrometry.

Abstract: Methods for producing and using protein/peptide fingerprints, allowing identification and investigation of disease-associated proteins/peptides that can be linked to specific drug targets, or to specific drug target combinations. The methods are particularly useful for studies relating to Chronic Obstructive Pulmonary Disease (COPD), especially for the enzyme MMP12.

Abstract: Methods for producing and using protein/peptide fingerprints, derived from elastin degraded by the enzyme human Neutrophil Elastase (HNE), allowing identification and investigation of disease-associated proteins/peptides that can be linked to specific drug targets, or to specific drug target combinations. The methods are particularly useful for studies relating to Chronic Obstructive Pulmonary Disease (COPD).

Abstract: The present invention relates to the identification of biomarkers for the disease condition COPD. The uses of such biomarkers in diagnosis and therapy and a novel method for their identification is are also described.

Abstract: Methods for producing and using protein/peptide fingerprints, allowing identification and investigation of disease-associated proteins/peptides that can be linked to specific drug targets, or to specific drug target combinations. The methods are particularly useful for studies relating to Chronic Obstructive Pulmonary Disease (COPD), especially for the enzyme MMP12.

Abstract: The invention relates to devices and methods for chemical analysis, specifically to devices for extracting molecules, e.g. biomolecules such as peptides, and/or proteins, from a mixture of molecules in a solution and performing sample treatment on the extracted molecules before presenting them to an analysis instrument. The method for analysis of samples uses a combined sample treatment and sample carrier device. Said device comprises a plate with inlets at one side connected to respective compartments situated at respective array positions for receiving samples to be treated and analysed, each compartment being in communication with an outlet enabling fluid flow through the plate.

Abstract: A processing module for extracting certain biomolecules from a solution, comprising an extraction unit having at least one elongated channel (101) each of said at least sine channel have un inlet (102) and an outlet (103) and being provided with adhering units (201), each said unit being provided with adhesive means, having affinity for said certain biomolecules, said extraction unit further comprises docking means (205) having an inlet array and an outlet array, that enables the extractor to be docked to and undocked from other devices having corresponding docking means, such that said solution or another fluid can be made to flow from said other devices, entering the inlet array, to flow through the at least one channels(101) and to leave the extraction device via the outlet array.

Abstract: A method of selecting and identifying bio-molecules present in a bio-sample is disclosed. The method comprises the steps of: obtaining a bio-sample; amplifying (2) the bio-molecules present in the bio-sample to improve the case of detection of said bio-molecules; separating the bio-molecules in said amplified bio-sample; depositing (3) the amplified bio-molecules on to a suitable media. Detecting means are then used to identify or detect the presence of bio-molecules in said amplified and separated sample wherein said amplification step occurs in close physical proximity to said deposition step. A device (1) for carrying out the method is also disclosed as is a protein chip library produced by the device or method.

Abstract: A dispensing device for use in chemical analysis comprising at least two dispenser nozzles, a chamber having at least two inlets, a membrane entity constituting part of defining elements of said chamber, said membrane entity comprising at least one flexible membrane, and an actuation element, such that liquids brought to flow through said inlets into said chamber can be pressurised by actuating the membrane entity by providing a pulse to said actuation element, and thereby dispensing an amount of liquid through each of said at least two nozzles. Embodiments include devices comprising integrated free flow electrophoresis separation means.

Abstract: The invention relates to a method and a machine for biomolecule handling using an array dispenser. More particularly, the invention relates to a method and a machine in which one or two separation procedures are performed in parallel channels and the separated biomolecules are deposited on a two-dimensional target plate for analysis e.g. in a MALDI TOF MS device (Matrix Assisted Laser Desorption/Ionisation Time-of-Flight Mass Spectrometry). A method of sample handling comprises the following steps: supplying (101) a number of samples to a multichannel separation device having an equal number of separation channels; separating (102) the samples in parallel in said number of separation channels; supplying said channels to an array dispenser after separation; dispensing (103) said channels in parallel on to a target plate maintaining the separation of the multichannel separation device.

Abstract: A device and method useable for fast processing and depositing of biomolecules. The method includes the following steps: receiving a first set of analytes to be analysed; passing in an array format, analytes through extraction means where said biomolecules adhere to solid phase means; washing said solid phase means with a washing liquid, leaving only said biomolecules; performing elution by passing portions of organic solvent through each said solid phase, forming eluates constituting a second set of analytes containing said biomolecules, as a result of said elution; dispensing, in an array format, said second set of analytes using a micro dispensing array; controlling said array to dispense precise amounts of each one of said second set of analytes on target areas of a target plate.

Abstract: A plate suitable for use with mass spectrometers comprising a number of target spots arranged in a surface portion of said plate making it possible to deposit small amounts of fluid at said target spots without the fluid escaping or getting mixed with fluid deposited at another target surface of the same plate. The target surfaces being arranged in a surface portion of said plate so that a base material of said plate constitutes the walls of receptacles, characterised in that the shape, size, temperature and possible agents of said receptacle facilitate evaporation of a solution in which sample molecules are suspended. Embodiments include different types of matrix and enzymes arranged at said spots, and methods for enhancing MALDI analysis efficiency.

Abstract: A device for conducting integrated sequential separation and enrichment of a mixture of sample proteins, comprising means for separation and means for enrichment, whereby free flow electrophoresis—isoelectric focussing (FFE-IEF), is arranged to take place within an etched system of basins and channels is preferably employed in the separation step, multichannel conduits are used to guide the separated protein fractions to the enrichment stage, and a solid phase micro-extraction procedure, in an optionally dockable format, is preferably employed in the enrichment step. The separated fractions are then preferably dispensed onto a MALDI-plate for subsequent matrix assisted laser desorption ionisation (MALDI) analysis.